Higher anxiety and perceived trauma among COVID-19 patients: a prospective comparative study.
Anxiety
COVID-19
Coronavirus
Depression
OCD
Obsessions-compulsion-disorder
Perceived trauma
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
09 02 2023
09 02 2023
Historique:
received:
28
05
2022
accepted:
27
01
2023
entrez:
10
2
2023
pubmed:
11
2
2023
medline:
14
2
2023
Statut:
epublish
Résumé
Psychiatric disorders such as anxiety, depression, and traumatic stress are not rare during infectious outbreaks, as the COVID-19 pandemic has posed a great concern to the general population. In this study, we aimed to investigate whether experiencing psychiatric symptoms during COVID-19 is the result of the burden of carrying an illness or the COVID-19 itself. Two hundred ten subjects and three different groups of participants (COVID-19 patients, university staff, and orthopedic patients) were recruited. They answered a demographic questionnaire, Yale-Brown Obsessive-Compulsive Scale (YBOCS) test for OCD symptoms, Impact of Event Scale-Revised (IES-R) for perceived trauma, Beck Anxiety Inventory (BAI) for anxiety, and Beck Depression Inventory (BDI) for depression assessments using phone or face-to-face interviews. At least one OCD symptom was observed in 85.7% of the subjects. However, there was no significant difference between the 3 groups (p = 0.2194). Perceived trauma was significantly higher among COVID-19 patients followed by university staff and orthopedic patients (23.73, 16.21, 11.51 mean IES-R scores respectively, p = 8.449e Perceived trauma and anxiety symptoms are significantly higher in COVID-19 patients and the symptoms of OCD and depression do not differ between COVID-19 and non-COVID-19 people, so the necessity of screening and following treatment of patients with COVID-19 should be kept in mind. IR.IUMS.FMD.REC.1399.761.
Sections du résumé
BACKGROUND AND PURPOSE
Psychiatric disorders such as anxiety, depression, and traumatic stress are not rare during infectious outbreaks, as the COVID-19 pandemic has posed a great concern to the general population. In this study, we aimed to investigate whether experiencing psychiatric symptoms during COVID-19 is the result of the burden of carrying an illness or the COVID-19 itself.
METHOD
Two hundred ten subjects and three different groups of participants (COVID-19 patients, university staff, and orthopedic patients) were recruited. They answered a demographic questionnaire, Yale-Brown Obsessive-Compulsive Scale (YBOCS) test for OCD symptoms, Impact of Event Scale-Revised (IES-R) for perceived trauma, Beck Anxiety Inventory (BAI) for anxiety, and Beck Depression Inventory (BDI) for depression assessments using phone or face-to-face interviews.
RESULT
At least one OCD symptom was observed in 85.7% of the subjects. However, there was no significant difference between the 3 groups (p = 0.2194). Perceived trauma was significantly higher among COVID-19 patients followed by university staff and orthopedic patients (23.73, 16.21, 11.51 mean IES-R scores respectively, p = 8.449e
CONCLUSION
Perceived trauma and anxiety symptoms are significantly higher in COVID-19 patients and the symptoms of OCD and depression do not differ between COVID-19 and non-COVID-19 people, so the necessity of screening and following treatment of patients with COVID-19 should be kept in mind.
TRIAL REGISTRATION
IR.IUMS.FMD.REC.1399.761.
Identifiants
pubmed: 36759783
doi: 10.1186/s12888-023-04574-6
pii: 10.1186/s12888-023-04574-6
pmc: PMC9909645
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
100Informations de copyright
© 2023. The Author(s).
Références
Psychiatry Investig. 2021 May;18(5):426-433
pubmed: 33910325
J Bone Joint Surg Am. 2004 Aug;86(8):1819-22
pubmed: 15292432
Psychiatr Danub. 2021 Sep;33(Suppl 10):161-171
pubmed: 34672291
Chonnam Med J. 2015 Apr;51(1):8-18
pubmed: 25914875
Depress Anxiety. 2005;21(4):185-92
pubmed: 16075452
Int J Environ Res Public Health. 2021 Sep 24;18(19):
pubmed: 34639341
Sci Rep. 2020 Dec 1;10(1):20957
pubmed: 33262404
Front Psychiatry. 2018 Sep 11;9:431
pubmed: 30254588
Rev Environ Health. 2020 Aug 31;36(1):1-8
pubmed: 32866131
Front Psychol. 2020 Nov 25;11:609815
pubmed: 33324307
Brain Behav Immun. 2020 Oct;89:594-600
pubmed: 32738287
Ann Intern Med. 2022 Nov;175(11):1560-1571
pubmed: 36252247
J Med Case Rep. 2021 Oct 18;15(1):523
pubmed: 34663466
Neurol Sci. 2022 Apr;43(4):2231-2239
pubmed: 35059902
Int J Environ Res Public Health. 2021 Feb 23;18(4):
pubmed: 33672257
Int J Environ Res Public Health. 2021 Apr 20;18(8):
pubmed: 33924236
Global Health. 2021 Jan 5;17(1):3
pubmed: 33402174
Rheumatol Int. 2020 Aug;40(8):1229-1238
pubmed: 32572609
Front Psychiatry. 2021 Aug 02;12:692498
pubmed: 34408679
Int J Environ Res Public Health. 2021 May 26;18(11):
pubmed: 34073524
Int J Environ Res Public Health. 2020 Sep 24;17(19):
pubmed: 32987764
BMC Psychiatry. 2021 Aug 3;21(1):385
pubmed: 34344329
J Affect Disord. 2021 Mar 1;282:527-538
pubmed: 33433382
Curr Psychiatry Rep. 2005 Aug;7(4):245-51
pubmed: 16098277
Psychiatry Res. 2021 Jan;295:113599
pubmed: 33285346
Epidemiol Prev. 2021;45(6):552-558
pubmed: 34711043
Brain Behav Immun. 2021 Oct;97:328-348
pubmed: 34339806
Anaesthesia. 2021 Sep;76(9):1224-1232
pubmed: 34189735